Navigation Links
The yin and yang in the life of proteins
Date:10/22/2013

Recycling or "scrap press": physicians at the Ruhr-Universitt have found out which molecular mechanisms decide about the fate of the import receptor Pex18. Pex18 is responsible for the import of proteins into specific cell components, namely peroxisomes. Two opposing regulatory circuits determine whether the receptor remains active or is broken down after the transport has been completed. "Thus, the picture of the regulation of the protein import into peroxisomes has been completed and integrated to form one single model," says Junior Professor Dr Harald Platta from the RUB Faculty of Medicine. Together with Prof Dr Ralf Erdmann and other colleagues he reports in the journal "Traffic".

Ubiquitin signals determine the fate of the receptors

Because they don't have their own DNA, peroxisomes have to import all proteins that are necessary for them to fulfil their function. For this purpose, the cell is equipped with dynamic import receptors such as Pex18. They bind proteins in the cytoplasm and transport them to the peroxisome. The RUB team had demonstrated in a previous study that the signal protein ubiquitin subsequently decides about the future fate of the receptors: if a single ubiquitin protein docks with the receptor, the receptor gets recycled; it migrates back into the cytoplasm and launches a new transport process. If an ubiquitin chain docks with the receptor, a signal is sent out for the receptor to be broken down by the proteasome, an "intracellular scrap press", so to speak. Prior to this discovery, it had not been understood in what way the cell determines on the molecular level what happens to the receptor.

Recycling or "scrap press": It all depends on the enzyme cascade

The RUB physicians found out that different enzyme cascades catalyse the two ubiquitin modifications of Pex18. In both cases, it is a three-step process: the E1 enzyme activates the ubiquitin signal which is subsequently transferred by the E2 enzyme and, eventually, coordinated by the E3 enzyme to dock with the receptor. By analysing yeast cells, the Bochum physicians found out that E2 and E3 enzymes occur in different variations, whereas there is only one type of the E1 enzyme. The docking of one single ubiquitin and an ubiquitin chain is determined by different combinations of E2 and E3 enzymes. "That means two opposing molecular machines determine the fate of the import receptor Pex18," says Harald Platta. "This discovery illustrates just how precisely the receptor's control is calibrated and how precisely the regulation associated with it is effected for the entire peroxisomal function. This project constitutes a crucial foundation for further research into the molecular causes of peroxisomal disorders."

Peroxisomes: The cell's multi-functional tools

Peroxisomes are important reaction states within the cell. They may contain up to 50 enzymes which are crucial for breaking down of fatty acids, for the disposal of hydrogen peroxide and the generation of plasmalogens which are an important component of the brain's white matter. A disruption of the protein import in peroxisomes has a negative impact on the entire metabolism and may be fatal especially for newborns.


'/>"/>

Contact: Dr. Harald W. Platta
Harald.Platta@rub.de
49-234-322-4968
Ruhr-University Bochum
Source:Eurekalert

Related biology news :

1. Zinc, proteins, and an essential cellular balancing act
2. Erratic proteins: New insights into a transport mechanism
3. Wistar scientists decipher structure of NatA, an enzyme complex that modifies most human proteins
4. Scientists decipher cellular roadmap of disease-related proteins
5. Toronto team IDs proteins key in stem cell production
6. Toronto team ID proteins key in stem cell production
7. Low levels of toxic proteins linked to brain diseases, study suggests
8. National Institutes of Health to fund research probing proteins linked to cancer, diabetes
9. Saliva proteins may protect older people from influenza
10. KISS ME DEADLY proteins may help improve crop yields
11. Metabolic fingerprinting: Using proteomics to identify proteins in gymnosperm pollination drops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
Breaking Biology Technology: